SCHEMBL3844161

SCHEMBL3844161

CC(C)COC(=O)N1CCC(COc2ccc(-c3ccc(S(C)(=O)=O)cc3)cc2)CC1

nearest known ligand 0.55

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 15/20 0.55
MMP13 P45452 1/20 0.47
CHRM2 P08172 1/20 0.47
CHRM1 P11229 1/20 0.47
GPR183 P32249 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2881232 0.90 GPR119 (0.61) GPR119GPR183
SCHEMBL2881607 0.90 GPR119 (0.58) GPR119GPR183
SCHEMBL2881337 0.89 GPR119 (0.56) GPR119CHRM2CHRM1GPR183
SCHEMBL2876265 0.88 GPR119 (0.56) GPR119GPR183
SCHEMBL2881115 0.88 GPR119 (0.52) GPR119CHRM2CHRM1
SCHEMBL2881370 0.88 GPR119 (0.51) GPR119MMP13
SCHEMBL387564 0.87 GPR119 (0.69) GPR119
SCHEMBL2876156 0.87 GPR119 (0.58) GPR119MMP13
SCHEMBL2883378 0.87 GPR119 (0.56) GPR119
SCHEMBL2879359 0.86 GPR119 (0.52) GPR119

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2094683-A2 BICYCLIC COMPOUNDS AND USE AS ANTIDIABETICS SmithKline Beecham Corporation (US) 2009-09-02 EP disclosed
WO-2008070692-A2 BICYCLIC COMPOUNDS AND USE AS ANTIDIABETICS SMITHKLINE BEECHAM CORPORATION (US) 2008-06-12 WO disclosed